Senior Director, CMC Program Management (Phase 3)

Kymera Therapeutics is a clinical-stage biotechnology company seeking a Sr. Director of CMC to lead end-to-end CMC program management for mid-to-late-stage programs, shaping timelines for drug substance, product, analytical, and regulatory workstreams in collaboration with CDMOs/CROs.

You will guide Phase 3 planning, technology transfer, and regulatory filings, build integrated plans, drive risk assessments, and mentor cross-functional teams to ensure on-time delivery of high-quality